(Q50772219)

English

Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.

scientific article published in February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

multiple sclerosis

0 references

Massimiliano Castellazzi

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

Enrico Granieri

7

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

author name string

E Fainardi

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

R Rizzo

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

L Melchiorri

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

E Paolino

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

M R Tola

6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

O R Baricordi

8

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

12

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

2-12

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway,.

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Regulatory functions of CD8+CD28– T cells in an autoimmune disease model

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

A role for natural killer cells in the immunopathogenesis of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

The regulatory role of natural killer cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

HLA-G: a shield against inflammatory aggression

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Biology and functions of human leukocyte antigen-G in health and sickness

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Intrathecal synthesis of soluble class I antigens in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy.

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Development of biomarkers in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells

1 reference

https://api.crossref.org/works/10.1191%2F1352458506MS1241OA

21 January 2018

Identifiers

10.1191/1352458506MS1241OA

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/16459714

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50772219&oldid=932573220"